This article is more than 5 years old. Information may no longer be current.

aap Implantate AG receives notice of allowance for silver coating patent

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The United States Patent and Trademark Office issued a notice of allowance to aap Implantate AG for its silver coating patent.

According to a company press release, the fundamental nature of the technology is in the property of silver as a coating material for medical devices to prevent biofilm formation and reduce infection risk. The silver coating as a platform technology can be applied to the existing trauma portfolio and other orthopedic implants.

“We are excited about this advancement in the development of our silver coating technology which extends our intellectual property protected trauma portfolio,” Bruke Seyoum Alemu, chief operating officer of aap Implantate AG, stated in the release. “Complementing our existing LOQTEQ portfolio, silver-coated implants will strengthen aap’s strategy to offer added-value trauma products addressing the growing infection care market.”